Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

Date of this announcement

Wednesday December 08, 2021

The +securities the subject of this notification are:

Other

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

New class - code

Unlisted options with exercise price of $0.40 and

5,000,000

07/12/2021

to be confirmed

expiry 5 years from grant date (21/06/2026)

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

13102832995

1.3

ASX issuer code

NSB

  1. The announcement is New announcement
  2. Date of this announcement

8/12/2021

Notification of Issue, Conversion or Payment up of Unquoted

2 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

For personal use only

2.1 The +securities the subject of this notification are: Other

Please specify

Issue of options as previously announced in Appendix 3B released on 22 June 2021.

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code ("new class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX

in an Appendix 3B

only

New +securities

ASX +security code

+Security description

New class - code to be confirmed

Unlisted options with exercise price of $0.40 and expiry 5

years from grant date (21/06/2026)

+Security type

ISIN code

use

Options

Date the +securities the subject of this notification were issued

7/12/2021

Will all the +securities issued in this class rank equally in all respects from their issue date?

personal

Yes

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under

listing rule 6.1?

No

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being

issued.

Material terms of the options were set out in the Appointment of Non-executive Chairman announcement lodged with the

ASX on 22 June 2021.

Options Details

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.40000000

21/6/2026

For

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of

company option

Other

Description

One fully paid ordinary share (ASX:NSB)

Any other information the entity wishes to provide about the +securities the subject of this notification

N/A

Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including why the issue of the +securities has not been previously announced to

Notification of Issue, Conversion or Payment up of Unquoted

4 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

the market in an Appendix 3B

N/A

Issue details

For personal use only

Number of +securities

5,000,000

Were the +securities issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Offered as part of appointment as non-executive chairman

Purpose of the issue

Other

Additional Details

Offered as part of appointment as non-executive chairman

Notification of Issue, Conversion or Payment up of Unquoted

5 / 7

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

NeuroScientific Biopharmaceuticals Ltd. published this content on 08 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 December 2021 04:11:07 UTC.